FIREBIRD BIOMOLECULAR SCIENCES LLC SBIR Phase I Award, April 2021
A SBIR Phase I contract was awarded to Firebird Biomolecular Sciences in April, 2021 for $258,854.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.